We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

43 hedge funds and large institutions have $3.72M invested in CERo Therapeutics Warrants in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

5% more funds holding

Funds holding: 41 → 43 (+2)

1% more capital invested

Capital invested by funds: $3.7M → $3.72M (+$20.9K)

Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
2
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$53.1K
2
MF
Magnetar Financial
Illinois
+$11.7K
3
BCM
Basso Capital Management
Connecticut
+$3.16K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$2.33K
5
SFM
Spartan Fund Management
Canada
+$2.1K

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$13K
2
HIM
HGC Investment Management
Ontario, Canada
-$4.21K
3
VF
Virtu Financial
New York
-$2K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$303
5
BI
Bulldog Investors
New Jersey
-$136
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$1.65M – – –
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.51M – – –
PC
3
Periscope Capital
Ontario, Canada
$86K +$53.1K +630,998 +210%
SCM
4
Segantii Capital Management
Hong Kong
$50K – – –
HCM
5
Highbridge Capital Management
New York
$38K – – –
MI
6
MMCAP International
Cayman Islands
$30K – – –
CF
7
Cantor Fitzgerald
New York
$29K – – –
LA
8
Linden Advisors
New York
$27K – – –
CS
9
Clear Street
New York
$27K +$472 +5,600 +2%
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$24K – – –
SCM
11
Saba Capital Management
New York
$24K – – –
AA
12
AQR Arbitrage
Connecticut
$20K – – –
ACM
13
Atalaya Capital Management
New York
$18K – – –
TI
14
Telemetry Investments
New York
$18K – – –
MF
15
Magnetar Financial
Illinois
$17K +$11.7K +138,950 +676%
CCM
16
Context Capital Management
California
$16K – – –
CH
17
CVI Holdings
Delaware
$14K – – –
QGA
18
Q Global Advisors
Texas
$12K – – –
Parallax Volatility Advisers
19
Parallax Volatility Advisers
California
$9K -$42 -500 -0.4%
NAM
20
Nexpoint Asset Management
Texas
$9K – – –
AGM
21
Alpine Global Management
New York
$8K +$42 +500 +0.9%
KL
22
KIM LLC
Kansas
$7K – – –
SRCM
23
Sage Rock Capital Management
New York
$7K – – –
KPF
24
K2 Principal Fund
Ontario, Canada
$6K – – –
WAM
25
Wolverine Asset Management
Illinois
$6K – – –
1
2

CEROW Hedge Fund Activity: Q3 2022 in Review

43 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q3 2022, worth a combined $3.72M — up 0.57% from $3.7M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CEROW positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Periscope Capital, adding an estimated $53.1K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $13K sold.

  • 43 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q3 2022, up from 41 in Q2 2022.
  • Funds reported $3.72M of CERo Therapeutics Warrants stock for Q3 2022, up 0.57% quarter-over-quarter.
  • 4 funds opened new CERo Therapeutics Warrants positions in Q3 2022 and 2 closed out, a net change of +2 holders.
  • The largest CERo Therapeutics Warrants buyer in Q3 2022 was Periscope Capital, an estimated $53.1K added.
  • The largest CERo Therapeutics Warrants seller in Q3 2022 was Fir Tree Capital Management, an estimated $13K sold.

Based on aggregated 13F filings for Q3 2022.